ASSURE
"ASSURE" is no longer active. Dead trademarks are generally available to file, but you should verify no similar active marks exist in the same class before proceeding.
ASSURE is registered to cover liquid biopsy testing for cancer cells using predictive markers and signatures directed to exome and transcriptome molecular profiling and biopsy testing assays using circulating nucleic acids sequencing (cNAS) for analysis of Whole Exome (cfDNA) and Whole Transcriptome (cfRNA) genes
Caris MPI, Inc. is a mid-size portfolio holder with active trademark management, with 28 trademark filings on record (9 currently active), spanning 14 years of filing activity.
This application represents a specialized filing in Class 44, filed in October 2023, as trademark filing volumes were normalizing.